Echocardiographic aortic valve calcification and outcomes in women and men with aortic stenosis. 2017

Henrik K Thomassen, and Giovanni Cioffi, and Eva Gerdts, and Eigir Einarsen, and Helga Bergljot Midtbø, and Costantino Mancusi, and Dana Cramariuc
Department of Clinical Science, University of Bergen, Bergen, Norway.

Sex differences in risk factors of aortic valve calcification (AVC) by echocardiography have not been reported from a large prospective study in aortic stenosis (AS). AVC was assessed using a prognostically validated visual score and grouped into none/mild or moderate/severe AVC in 1725 men and women with asymptomatic AS in the Simvastatin Ezetimibe in Aortic Stenosis study. The severity of AS was assessed by the energy loss index (ELI) taking pressure recovery in the aortic root into account. More men than women had moderate/severe AVC at baseline despite less severe AS by ELI (p<0.01). Moderate/severe AVC at baseline was independently associated with lower aortic compliance and more severe AS in both sexes, and with increased high-sensitive C reactive protein (hs-CRP) only in men (all p<0.01). In Cox regression analyses, moderate/severe AVC at baseline was associated with a 2.5-fold (95% CI 1.64 to 3.80) higher hazard rate of major cardiovascular events in women, and a 2.2-fold higher hazard rate in men (95% CI 1.54 to 3.17) (both p<0.001), after adjustment for age, hypertension, study treatment, aortic compliance, left ventricular (LV) mass and systolic function, AS severity and hs-CRP. Moderate/severe AVC at baseline also predicted a 1.8-fold higher hazard rate of all-cause mortality in men (95% CI 1.04 to 3.06, p<0.05) independent of age, AS severity, LV mass and aortic compliance, but not in women. In conclusion, AVC scored by echocardiography has sex-specific characteristics in AS. Moderate/severe AVC is associated with higher cardiovascular morbidity in both sexes, and with higher all-cause mortality in men. ClinicalTrials.gov identifier: NCT00092677.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002114 Calcinosis Pathologic deposition of calcium salts in tissues. Calcification, Pathologic,Calcinosis, Tumoral,Microcalcification,Microcalcinosis,Pathologic Calcification,Calcinoses,Calcinoses, Tumoral,Microcalcifications,Microcalcinoses,Tumoral Calcinoses,Tumoral Calcinosis
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069438 Ezetimibe An azetidine derivative and ANTICHOLESTEREMIC AGENT that inhibits intestinal STEROL absorption. It is used to reduce total CHOLESTEROL; LDL CHOLESTEROL, and APOLIPOPROTEINS B in the treatment of HYPERLIPIDEMIAS. (1-(4-fluorophenyl)-(3R)-(3-(4-fluorophenyl)-(3S)-hydroxypropyl)-(4S)-(4-hydroxyphenyl)-2-azetidinone),Ezetimib,Ezetrol,SCH 58235,SCH-58235,SCH58235,Zetia,58235, SCH
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000924 Anticholesteremic Agents Substances used to lower plasma CHOLESTEROL levels. Cholesterol Inhibitors,Hypocholesteremic Agents,Anticholesteremic Drugs,Anticholesteremics,Inhibitors, Cholesterol,Agents, Anticholesteremic,Agents, Hypocholesteremic,Drugs, Anticholesteremic
D001021 Aortic Valve The valve between the left ventricle and the ascending aorta which prevents backflow into the left ventricle. Aortic Valves,Valve, Aortic,Valves, Aortic

Related Publications

Henrik K Thomassen, and Giovanni Cioffi, and Eva Gerdts, and Eigir Einarsen, and Helga Bergljot Midtbø, and Costantino Mancusi, and Dana Cramariuc
September 2023, Heart (British Cardiac Society),
Henrik K Thomassen, and Giovanni Cioffi, and Eva Gerdts, and Eigir Einarsen, and Helga Bergljot Midtbø, and Costantino Mancusi, and Dana Cramariuc
March 1978, Ceskoslovenska patologie,
Henrik K Thomassen, and Giovanni Cioffi, and Eva Gerdts, and Eigir Einarsen, and Helga Bergljot Midtbø, and Costantino Mancusi, and Dana Cramariuc
April 2018, The American journal of cardiology,
Henrik K Thomassen, and Giovanni Cioffi, and Eva Gerdts, and Eigir Einarsen, and Helga Bergljot Midtbø, and Costantino Mancusi, and Dana Cramariuc
January 2020, Current atherosclerosis reports,
Henrik K Thomassen, and Giovanni Cioffi, and Eva Gerdts, and Eigir Einarsen, and Helga Bergljot Midtbø, and Costantino Mancusi, and Dana Cramariuc
September 1978, Annals of internal medicine,
Henrik K Thomassen, and Giovanni Cioffi, and Eva Gerdts, and Eigir Einarsen, and Helga Bergljot Midtbø, and Costantino Mancusi, and Dana Cramariuc
June 2017, European heart journal. Cardiovascular Imaging,
Henrik K Thomassen, and Giovanni Cioffi, and Eva Gerdts, and Eigir Einarsen, and Helga Bergljot Midtbø, and Costantino Mancusi, and Dana Cramariuc
June 2018, Current treatment options in cardiovascular medicine,
Henrik K Thomassen, and Giovanni Cioffi, and Eva Gerdts, and Eigir Einarsen, and Helga Bergljot Midtbø, and Costantino Mancusi, and Dana Cramariuc
April 2019, JACC. Basic to translational science,
Henrik K Thomassen, and Giovanni Cioffi, and Eva Gerdts, and Eigir Einarsen, and Helga Bergljot Midtbø, and Costantino Mancusi, and Dana Cramariuc
September 2019, JACC. Cardiovascular imaging,
Henrik K Thomassen, and Giovanni Cioffi, and Eva Gerdts, and Eigir Einarsen, and Helga Bergljot Midtbø, and Costantino Mancusi, and Dana Cramariuc
September 2020, JACC. Cardiovascular imaging,
Copied contents to your clipboard!